Although research investigating the therapeutic potential of RNA has been ongoing since the 1970s, its novel use as a vaccine platform to target the SARS‑CoV‑2 virus during the COVID-19 pandemic brought this technology centre-stage.
The first large-scale application of mRNA during the COVID-19 pandemic has been hailed as an unprecedented scientific achievement, and advancements in next-generation mRNA technologies are poised to transform health care as they can flexibly be applied and scaled to treat and prevent many different conditions — yet growing public mistrust and polarization surround mRNA technology.
To further explore public sentiment and strengthen trust in these technologies, the BRC has gathered social and behavioural insights using a range of methodologies, including social media analysis, a national survey, community dialogues, and literature reviews.



